SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2023 Supreme(Del) 1578

IN THE HIGH COURT OF DELHI AT NEW DELHI
C. Hari Shankar, J.
Sun Pharma Laboratories Ltd. – Appellant
Versus
Windlas Biotech Ltd & Anr. – Respondents
CS(COMM) 302 of 2022 & I.A. 7290 of 2022, I.A. 7291 of 2022, I.A. 17788 of 2022, I.A. 6858 of 2023, I.A. 10812 of 2023
Decided On : 01-06-2023

Advocates appeared:
Mr. Sachin Gupta and Mr.Manan Mandal, Advocates, for the Plaintiff.
Mr. Anant Prakash, Advocate, for D-2.

The court can decree a suit in terms of a settlement agreed upon by the parties under Order XXIII Rule 3 of the CPC.

Headnote:

Settlement - Disputes between parties - Decree in terms of settlement

Fact of the Case:

The parties jointly filed an application under Order XXIII Rule 3 of the CPC praying for the suit to be decreed in terms of the settlement, which included various conditions and confirmations by the defendants.

Finding of the Court:

The Court found the terms of settlement to be lawful and in order, and as a result, nothing remained for adjudication in the present suit. The suit was decreed in terms of the settlement, and the plaintiff was entitled to a complete refund of court fee, if any.

Issues: Disputes between parties, terms of settlement, decree in terms of settlement, refund of court fee

Ratio Decidendi: The court's decision was influenced by the lawful and in order terms of settlement agreed upon by the parties, which led to the decree of the suit in terms of the settlement and the disposal of miscellaneous applications.

Final Decision: The suit was decreed in terms of the settlement, and the plaintiff was entitled to a complete refund of court fee, if any.

ORDER (Oral)

I.A. 10812/2023 in CS(COMM) 302/2022

1. The disputes between the parties stand settled and the present application has been jointly filed by them under Order XXIII Rule 3 of the CPC praying that the suit be decreed in terms of the said settlement. The terms of the settlement read thus:

    "i. The Defendants state that there are no existing stocks of finished products under the impugned mark PANTRACID and its extensions thereof available with them;

    ii. The Defendants state that they have destroyed all the stationary, packaging, promotional and publicity material and labels under the impugned mark being PANTRACID and its extensions thereof;

    iii. The Defendants confirm that apart from the batches of the impugned product under the mark PANTRACID and its extensions thereof, no other batches have been manufactured or sold by the Defendants. The Defendants confirm that below are the batches which have not yet expired and are currently in the market under the impugned mark. The said batch details are as follows:

Impugned Product/formsBatch No.
PANTRACID GELWPG21001
PANTRACID GELWPG21002
PANTRACID GELWPG22001
PANTRACID MPS SUSPENSIONTBHU1553
PANTRACID MPS SUSPENSIONTBHU1554
PANTRACID MPS SUSPENSIONTBHU1530
PANTRACID MPS SUSPENSIONTBHV0531
PANTRACID MPS SUSPENSIONTBHV0532
PANTRACID MPS SUSPENSIONTBHV0533
PANTRACID DSR CAPSULESBHC-2106075
PANTRACID DSR CAPSULESWPC21001
PANTRACID DSR CAPSULESWPC22001
PANTRACID DSR CAPSULESWPC22002
PANTRACID DSR CAPSULESWPC22003

    iv. The Defendants confirm that they shall destroy all kinds of packaging, publicity, advertisement and promotional material bearing mark PANTRACID and its variants in the presence of the Plaintiff's representative;

    v. The Defendant further confirm that they have directed removal of all the listings, bearing the impugned carton and inner foil packaging and its variants on their website or other social media handles, over which they have direct control;

    vi. Defendant confirms that the Defendant has not filed any trade mark and/or copyright application for impugned carton and inner foil packaging and its variants in India and/or abroad.

    viii. Defendant confirm that it shall not use, manufacture, trade, sale, offer to sale, advertise, marketing the products under trademark PANTRACID and its variants.

    viii. Defendant confirm that it shall not cause to use, manufacture, trade, sale, offer to sale, advertise, marketing the products under trademark PANTRACID and its variants.

    ix. The Plaintiff is foregoing costs and damages as sought in the plaint at the request of the Defendants."

2. The Court has perused the terms of settlement and find them to be lawful and in order.

3. In view of the aforesaid terms of settlement, nothing survives for adjudication in the present suit.

4. The suit accordingly stands decreed in terms of the aforesaid terms of settlement by which learned Counsel for the parties agreed that their clients would remain bound.

5. Let a decree sheet be drawn up accordingly. Miscellaneous applications are also stand disposed of.

6. The plaintiff would be entitled to complete refund of court fee, if any, deposited by it.

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top